Company Announcement Ethics Approval for CBD Topical Osteoarthritis Study October 21, 2021October 21, 2021
Company Announcement Dosing commences for Phase I human clinical trial October 4, 2021October 4, 2021
Company Announcement Enrolment commences for Phase I human clinical trial September 15, 2021September 15, 2021
Company Announcement TGA pre-submission meeting for insomnia related CBD soft-gel product May 26, 2021May 26, 2021
